Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens

Scandinavian Journal of Immunology

Volumn 53, Issue 4, 2001, Pages 401-409

  Decroix, N ^a   Hocini, H ^a   Quan, C P ^a   Bellon, B ^a   Kazatchkine, M D ^a,b   Bouvet, J P ^a,b  

^a Unité d'Immunopathologie humaine INSERM U430   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; HAPTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TETANUS TOXOID;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VAGINA DISCHARGE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; EPITOPES; FEMALE; HAPTENS; HIV ENVELOPE PROTEIN GP41; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SOLUBILITY; TETANUS TOXOID; TISSUE DISTRIBUTION; VACCINATION; VAGINA;

EID: 0035057311     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00894.x     Document Type: Article

References (44)

1. The B-cell system of human mucosae and exocrine glands
2. Molecular and cellular basis of immune protection of mucosal surfaces
3. The mucosal immune system: From fundamental concepts to vaccine development
4. Diversity of antibody-mediated immunity at the mucosal barrier
5. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein
6. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
7. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination
8. Arrangement of disulfide bridges and positions of sulfhydryl groups in tetanus toxin
9. Reversible denaturation of disulfide-reduced ovalbumin and its reoxidation generating the native cystine cross-link
10. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
11. Comparative molecular size of mouse IgA in different body fluids
12. Hepatobiliary transport of plasma IgA in the mouse: Contribution to clearance of intravascular IgA
13. Natural autoantibodies in nude and normal outbred (Swiss) and inbred (BALB/c) mice
14. Natural secretory immunoglobulin A polyreactive autoantibodies as a possible immune barrier in humans
15. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions
16. Glandular distribution of immunoglobulin, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle
17. Terminally differentiated human intestinal B cells. J chain expression of IgA and IgG subclass-producing immunocytes in the distal ileum compared with mesenteric and peripheral lymph nodes
18. Immunology of the oral mucosa in the mouse
19. Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract
20. Compartmentalization of the IgG immune response to HIV-1 in breast milk
21. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line
22. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
23. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
24. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice
25. Protection from lethal coronarovirus infection by immunoglobulin fragments
26. IgG surfaces as an important component in mucosal protection
27. Immune exclusion is a function of IgA
28. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells
29. Intracellular neutralization of virus by immunoglobulin A antibodies
30. Regional specialization in the mucosal immune system: Primed cells do not always home along the same tract
31. Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract
32. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit rectal, and urinary immune responses in nonhuman primates
33. History of Sabin attenuated poliovirus oral live vaccine strains
34. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable micoparticles containing antigen
35. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses
36. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response
37. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies
38. Local antibody response to poliovaccine in the human female genital tract
39. Salivary antibody responses to oral and parenteral vaccines in children
40. Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization
41. The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: Characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant
42. Aluminium is put on trial as a vaccine booster
43. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
44. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate